Total Funding
17
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 17 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Jaleva Pharmaceuticals offers a dermal drug delivery system that promotes transmucosal and topical delivery of medications.
- Alex Battaglia: Co-Founder
- Mordy Levine: CEO
About the Company
Jaleva Pharmaceuticals, LLC, a specialty pharmaceutical company, engages in the research and development of dermal drug delivery system that promotes transmucosal and topical delivery of medications for central nervous system markets. Its products include Mast-R-Prep, a chlorhexidine-based surgical skin prep product; and Stayzon, an antibiotic
surgical adhesive. The company’s formulations are designed to provide delivery of alprazolam for anxiety; ondansetron for nausea; sumitriptan for migraines; fentanyl for pain; and nicotine as an aid to smoking cessation. Jaleva Pharmaceuticals, LLC was founded in 1999 and is based in San Diego, California.
Women Founded
